Evaluation of nurse practitioner-led survivorship care.

Authors

null

Mary S. McCabe

Memorial Sloan Kettering Cancer Center, New York, NY

Mary S. McCabe , Annelies H. Boekhout , Bridgette Thom , Stacie Corcoran , Roberto Adsuar , Kevin C. Oeffinger

Organizations

Memorial Sloan Kettering Cancer Center, New York, NY, Netherlands Cancer Institute, Amsterdam, Netherlands

Research Funding

Other

Background: As the number of cancer survivors grows, new models of survivorship care are being implemented internationally, but there is limited evaluation of them to date. This retrospective review assesses the concordance of care provided to adult-onset cancer survivors in nurse practitioner (NP)-led clinics with Institute of Medicine (IOM) guidelines for comprehensive survivorship care. Methods: Records from three survivorship clinics were reviewed to determine frequency of surveillance for recurrence (SR), screening for second cancers, symptom management (physical, psychological), health promotion education (alcohol, tobacco, cholesterol, bone density screenings; discussions on diet, exercise), and care coordination (provision of care plan). Visit length and payor mix were also assessed. Data were characterized using descriptive statistics. Results: From 4Q 2011 - 3Q 2013, 9052 unique visits occurred within the three clinics; 210 breast, 208 prostate, and 204 colorectal visits were randomly selected from these visits for review. All breast patients underwent SR, and 99% received screenings for new primary cancers. Frequency of discussion of designated health promotion activities ranged from 83-100%; 91% of visits discussed physical symptoms, and 93% discussed psychological symptoms. In prostate, 100% of patients underwent SR; 97% were screened for new primaries. Health promotion frequency ranged from 70-97%, depending on activity, and 89% of visits discussed physical/psychological symptoms. In colorectal, all patients underwent a colonoscopy for SR; 97% had a CEA test. Of female colorectal patients, 97% had a mammogram, 96% had a Pap smear; 83% of male patients had a PSA test. Health promotion activities ranged from 69-100%, and 93-97% of visits discussed symptoms. Provision of care plans varied substantially among clinics, due in part to staffing and clinical systems issues: 36% prostate, 70% breast, and 92% colorectal. Conclusions: These findings suggest the success of NP-led clinics in providing quality survivorship care in accordance with IOM standards. While IOM guidelines are not considered a final authority, they provide normative standards. This assessment is an important step in evaluating survivorship outcomes.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Patient and Survivor Care

Track

Patient and Survivor Care

Sub Track

Survivorship

Citation

J Clin Oncol 34, 2016 (suppl; abstr 10081)

DOI

10.1200/JCO.2016.34.15_suppl.10081

Abstract #

10081

Poster Bd #

69

Abstract Disclosures

Similar Abstracts

Abstract

2024 ASCO Annual Meeting

Cost effectiveness of colorectal cancer screening in the Dominican Republic.

First Author: Yoanna S. Pumpalova

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Trends in colorectal cancer screening from NHIS survey: Analysis of modalities impact on overall screening.

First Author: Derek W. Ebner

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Impact of revising colorectal cancer screening guidelines on health care resources in Canada.

First Author: Brendan Chia